Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
EPS for Spero Therapeutics (SPRO)
EPS in 2023 (TTM): -$0.26
According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.26. In 2022 the company made an earnings per share (EPS) of -$1.66 an increase over its 2021 EPS that were of -$2.91.
EPS history for Spero Therapeutics from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.26 | -84.34% |
| 2022 | -$1.66 | -42.96% |
| 2021 | -$2.91 | -19.39% |
| 2020 | -$3.61 | 9.39% |
| 2019 | -$3.30 | 25.48% |
| 2018 | -$2.63 | -51.35% |
| 2017 | -$5.41 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 IBM IBM | $7.62 | -3,030.77% | 🇺🇸 USA |
 Thomson Reuters
TRI | $4.97 | -2,012.27% | 🇨🇦 Canada |
 Franklin Covey FC | $1.32 | -607.69% | 🇺🇸 USA |